Kairos Pharma, LTD. SEC filings KAPA
Kairos Pharma, LTD. has 125 filings in SEC EDGAR's recent list, going back to Mar 29, 2023. Its latest annual report, Form ARS, was filed on May 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Dec 30, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Dec 23, 2025 | Sep 16, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Sep 16, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Oct 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 3 | Initial insider ownership | Apr 30, 2025 | Dec 10, 2024 |
| 4 | Insider transaction | Apr 7, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Feb 24, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 21, 2024 | Nov 20, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 24, 2024 | Sep 16, 2024 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KAPA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1962011
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.